Andrew Derodra Acquires 127 Shares of Vectura Group PLC (VEC) Stock
Vectura Group PLC (LON:VEC) insider Andrew Derodra acquired 127 shares of the stock in a transaction that occurred on Wednesday, January 17th. The stock was purchased at an average price of GBX 118 ($1.60) per share, for a total transaction of £149.86 ($203.23).
Andrew Derodra also recently made the following trade(s):
- On Friday, December 8th, Andrew Derodra acquired 153 shares of Vectura Group stock. The stock was purchased at an average price of GBX 98 ($1.33) per share, for a total transaction of £149.94 ($203.34).
- On Wednesday, November 8th, Andrew Derodra acquired 156 shares of Vectura Group stock. The stock was purchased at an average price of GBX 96 ($1.30) per share, for a total transaction of £149.76 ($203.09).
Vectura Group PLC (LON:VEC) opened at GBX 111.80 ($1.52) on Friday. Vectura Group PLC has a twelve month low of GBX 86.50 ($1.17) and a twelve month high of GBX 166.97 ($2.26).
TRADEMARK VIOLATION WARNING: “Andrew Derodra Acquires 127 Shares of Vectura Group PLC (VEC) Stock” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another domain, it was stolen and republished in violation of US & international copyright law. The correct version of this article can be viewed at https://www.thecerbatgem.com/2018/01/20/andrew-derodra-acquires-127-shares-of-vectura-group-plc-vec-stock.html.
About Vectura Group
Vectura Group plc is engaged in research, development and commercialization of therapeutic products and drug delivery systems for human use. The Company’s products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) – LABA-LAMA; Seebri Breezhaler (EU and RoW) – LAMA; AirFluSal Forspiro (EU and RoW) – ICS-LABA; ADVATE (Global) – Antihaemophilic Factor (Recombinant); Adept (Global) – Icodextrin; Anoro Ellipta (Global) – LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) – ICS-LABA, and Incruse Ellipta (Global) – LAMA.
Receive News & Ratings for Vectura Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vectura Group and related companies with MarketBeat.com's FREE daily email newsletter.